EBR Systems, Inc. (ASX: EBR) has received FDA approval of the WiSE® System, which marks a significant leap forward in the treatment of heart failure. Unlike conventional CRT, the WiSE System is the ...

Imricor Medical Systems announced that it commenced a trial by completing its first-in-human ventricular ablation procedure.

EBR designed its WiSE system to significantly expand the population of patients who could benefit from CRT. The leadless ...

Adagio Medical Holdings, Inc. (Nasdaq: ADGM) ("Adagio" or "the Company"), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced that it has ...

The following is a summary of "Novel Right Ventricular Function Parameters Can Identify Short-Term Non-Responders To ...

Does walking count as exercise? Yes, walking is exercise, and experts across physical and mental health disciplines agree.

Special Report: Imricor Medical Systems has secured CE Mark certification for its Advantage-MR system under the European ...

The US FDA has approved EBR System's leadless pacemaker WISE, the only heart device able to deliver left-ventricle ...

Adagio Medical shares are trading higher by 142% during Thursday's session. The FDA granted Breakthrough Device Designation for the vCLAS cryoablation system.

Corporation will be exhibiting at the MedAxiom CV Transforum Spring’25 Conference being held at the Renaissance Orlando at SeaWorld ...

April is National Donate Life Month, a time to raise awareness about the critical need for organ donors and the life-saving ...

According to the Department of Pharmaceuticals' annual report for 2024-25, India imported medical devices worth $8.1 billion, ...